CTCF and cancer: The cancer‐related mutations L309P, R339Q and R377H affecting the ZF2, ZF3 and ZF4/5, respectively cause variable impact on CTCF binding to its cognate sites as assessed by ChIP (preprint: Bailey et al, 2021).